Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)
Clinical trial NCT05253118 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05253118
- Sponsor
- Seoul National University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-18
- Primary completion
- 2026-12-28
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.